On April 8, the "Lymphoma/Myeloma Diagnosis and Treatment Well-known Expert Team Outpatient Clinic" led by Professor Zhang Xi, Director of the Hematology Medical Center of Xinqiao Hospital of the Army Medical University and Changjiang Scholar, was officially launched, which will focus on the whole process of diagnosis and treatment of lymphoma and myeloma, and provide patients with more comprehensive and convenient outpatient services.
President Huang Jidong of Xinqiao Hospital, Director Yang Ting of the Medical Department and other leaders of the hospital, Professor Zhang Xi, Director of the Hematology Medical Center, Professor Gao Lei, Professor Zhang Cheng, Associate Professor Rao Jun, Director Yu Jiang of the Outpatient Department and relevant members of the department attended the launching ceremony. After the launching ceremony, Professor Zhang Xi led a team of experts to carry out an online live broadcast of popular science lectures through the "Chongqing Morning Post" "Re-reporting Health Douyin Account" and "Xinqiao Hospital Video Account", and Associate Professor Rao Jun and Associate Professor Xiang Qianqian gave health science lectures on "Unveiling the Mystery of Lymphoma" and "Taking You to Know "Crab Disease" respectively, which attracted the attention of nearly 10,000 netizens on multiple platforms.
In the past few decades, the incidence of lymphoma in the world has increased year by year, ranking among the top ten high-incidence tumors in the world and one of the malignant tumors with the fastest growth rate. Due to the complexity of its pathological types, the clinical cure rate of patients is higher after standardized individualized treatment. However, the current five-year survival rate for patients with lymphoma on the mainland is not high.
Multiple myeloma (MM) is a disease characterized by malignant proliferation of clonal plasma cells, with an incidence of 10% to 15% of hematologic malignancies in mainland China, and is the second most common hematologic malignancy, most commonly occurring in people aged 65 to 75 years, more males than females, and the incidence is increasing by 0.8% per year. Because the early symptoms often do not manifest as hematologic diseases, the missed diagnosis and misdiagnosis rate of the first visit is as high as about 60%.
Previously, the Hematology Medical Center of Xinqiao Hospital was entrusted by the National Health Commission Lymphoma Specialty Construction Project - Chongqing Pilot Project, and took the lead in releasing the clinical diagnosis and treatment pathways of multiple myeloma (MM) and diffuse large B cell lymphoma (DLBCL) in Chongqing, further improving the personalization and Targeted and standardized diagnosis and treatment to improve the quality of life of patients, improve the clinical cure rate, and prolong the survival time of patients.
In addition, the team of the Department of Lymphoid Oncology of the Hematology Medical Center of Xinqiao Hospital has innovated in the pretreatment of lymphoma transplantation in recent years, creating a new model of double autologous hematopoietic stem cell transplantation for the treatment of T lymphoblastic lymphoma for the first time, and at the same time building a new technology system of "double autologous hematopoietic stem cell transplantation for the treatment of T-cell lymphoma". It also released China's first "Chinese Expert Consensus on the Diagnosis and Treatment of Adult T-lymphoblastic Lymphoma", which strongly promoted the standardization and standardization of clinical diagnosis and treatment of this disease in China. The team has also pioneered chimeric antigen receptor T cell therapy (CAR-T) for lymphoma in western China, and has also made important breakthroughs in liquid biopsy of lymphoma, clarifying the feasibility of liquid biopsy technology in the monitoring of efficacy and prognosis of lymphoma, which is conducive to the realization of personalized treatment for patients.
The service model of the well-known expert team gives full play to the leading role of well-known experts, and through the "one-stop" service between teams, the well-known experts play a better role in "passing on and helping to lead", improve the diagnosis and treatment ability of team members, and can meet the reasonable medical needs of patients to the greatest extent, avoid blindly seeking well-known experts, and provide patients with more suitable medical treatment.
Professor Zhang Xi said, "There are many patients with hematological cancers who have survived for more than 10 or 20 years in our center, and standardized treatment and follow-up are the basis for achieving deep remission and prolonging survival. The newly launched clinic of well-known expert teams will also give full play to the expertise of experts in different fields of lymphoma and myeloma, and focus on the diagnosis and treatment of one disease, providing a more convenient channel for chronic disease management and follow-up diagnosis and treatment of lymphoma and myeloma patients. ”
Source: Xinqiao Hospital, Army Medical University
Correspondent: Zeng Li
Editors: Liu Zhenghui, Huang Menglin
Reviewer: Xie Tao
Issued: Daley Red
Picture: Some of the pictures in this article are from the Internet, the copyright belongs to the original author, if there is any infringement, please contact us to delete.